The EPS projection of Chimerix, Inc. (NASDAQ:CMRX) for quarter ended 2016-09-30 is $-0.49. Last week, the EPS forecast was $-0.49 against target of $-0.49, a month earlier. Two months ago, this estimate was $-0.49 versus forecast of $-0.49 three months earlier, implying a deviation of 0%.
Chimerix, Inc. (NASDAQ:CMRX) stated that 18 days ago, its stock price was positively revised 3 times while negative revisions were 0.
In last week, the experts lowered EPS 0 times and increased EPS 0 times. In last 30, 120, 60 and 90 days, the experts upped revisions 0 , 0, 4, and 4, correspondingly.
EPS estimate downgrade for Chimerix, Inc. (NASDAQ:CMRX) in the preceding 30, 120, 60 and 90 days were 0, 2, 1, and 1, correspondingly.
Chimerix, Inc. (NASDAQ:CMRX) EPS target for the quarter closed 1 was $-0.49, based on 7 recommendations. As reported on 2016-05-09 the EPS was $-0.57. The change was $0.1, implying a percentage deviation of 14.93%. The projections showed a standard deviation of 0.11.
Quarterly Sales Estimates
Chimerix, Inc. (NASDAQ:CMRX) yearly sales prediction for the fiscal 2016 stands at $1.849 and the median estimate is at $1.785. Almost 4 analysts issued sales target.
Highest sales target is $2.6 while the lowest target is $1.228 showing standard deviation of 0.714%.
As many as 4 analysts have sales targets revised upside while 4 reduced sales estimates, implying a deviation of 0%.
Last month, 4 revised sales number projection on upside while 4 lowered the sales projections, implying a deviation of 0%.
A quarter ago, 4 hiked sales target and 4 reduced sales forecast. Chimerix, Inc. (NASDAQ:CMRX) announced that the deviation in forecast was -30.904%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...